Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Conditions: C3 Glomerulopathy; Idiopathic Immune Complex-Mediated Glomerulonephritis Interventions: Drug: OMS906 study drug Sponsors: Omeros Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials